Genmab Says Rina-S Shows Significant PFS and Overall Survival Improvement
Genmab announced positive topline Phase 3 results for rinatabart sesutecan in patients with platinum-resistant ovarian cancer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.